av/gensight-biologics--big.svg

COM:GENSIGHT-BIOLOGICS

GenSight Biologics S.A.

  • Stock

EUR

Last Close

0.32

25/11 08:59

Market Cap

31.04M

Beta: -

Volume Today

88.55K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
net income
-4.15M
-
-8.30M
100%
-10.16M
22.31%
-10.16M
0%
-5.36M
47.26%
-10.71M
100%
-8.46M
21.08%
-8.46M
0%
-5.98M
29.26%
-11.96M
100%
-7.13M
40.40%
-7.13M
0%
-2.92M
58.98%
-2.92M
0%
depreciation and amortization
235.50K
-
432K
83.44%
228.50K
47.11%
228.50K
0%
273K
19.47%
484K
77.29%
257.50K
46.80%
257.50K
0%
329K
27.77%
495K
50.46%
760.50K
53.64%
760.50K
0%
286.50K
62.33%
286.50K
0%
deferred income tax
-6.05M
-
718K
111.87%
718K
0%
-63K
108.77%
1.40M
2,317.46%
stock based compensation
757.50K
-
757.50K
0%
1.66M
119.08%
1.66M
0%
-809K
148.75%
-809K
0%
-873K
7.91%
-873K
0%
83K
109.51%
83K
0%
211K
154.22%
211K
0%
197.50K
6.40%
197.50K
0%
change in working capital
-1.67M
-
-5.58M
233.87%
2.89M
151.85%
2.89M
0%
-712K
124.62%
-3.88M
444.66%
155K
104.00%
155K
0%
-20K
112.90%
443K
2,315%
3.18M
618.74%
3.18M
0%
43.50K
98.63%
43.50K
0%
accounts receivables
-1.06M
-
-3.90M
266.07%
715K
118.36%
715K
0%
223K
68.81%
-3.44M
1,641.26%
155K
104.51%
155K
0%
-20K
112.90%
347K
1,835.00%
19.50K
94.38%
19.50K
0%
-16.50K
184.62%
-16.50K
0%
inventory
accounts payables
-2.24M
-
-2.45M
-
2.12M
-
-863K
-
other working capital
-607K
-
553K
191.10%
2.18M
293.76%
2.18M
0%
-935K
142.94%
2.01M
315.29%
-2.03M
-
3.16M
256.12%
3.16M
0%
60K
98.10%
60K
0%
other non cash items
-278.50K
-
9.92M
3,660.50%
1.92M
80.69%
1.92M
0%
-1.74M
190.78%
3.92M
325.31%
-335K
108.55%
-335K
0%
-2.45M
631.94%
-6.93M
182.83%
-1.25M
81.92%
-1.25M
0%
-1.28M
1.75%
-1.28M
0%
net cash provided by operating activities
-5.11M
-
-10.53M
106.15%
-3.46M
67.14%
-3.46M
0%
-8.34M
141.07%
-17.05M
104.35%
-8.53M
49.95%
-8.53M
0%
-8.10M
5.03%
-16.48M
103.34%
-4.23M
74.35%
-4.23M
0%
-3.67M
13.13%
-3.67M
0%
investments in property plant and equipment
-5K
-
-10K
100%
-11K
10%
-11K
0%
-74.50K
577.27%
-149K
100%
-51.50K
65.44%
-51.50K
0%
-5K
-
-5K
0%
-500
90%
-500
0%
acquisitions net
purchases of investments
sales maturities of investments
250K
-
242K
-
153K
-
13K
-
other investing activites
125K
-
125K
0%
-117K
193.60%
-117K
0%
121K
203.42%
91K
-
91K
0%
76.50K
15.93%
33K
-
33K
0%
6.50K
80.30%
6.50K
0%
net cash used for investing activites
120K
-
240K
100%
-128K
153.33%
-128K
0%
46.50K
136.33%
93K
100%
39.50K
57.53%
39.50K
0%
76.50K
93.67%
153K
100%
28K
81.70%
28K
0%
6K
78.57%
6K
0%
debt repayment
-1.04M
-
-2.27M
-
-7.08M
-
common stock issued
28.10M
-
31K
-
53K
-
12.62M
-
common stock repurchased
-125K
-
-125K
0%
-27.50K
78%
-27.50K
0%
-121K
340%
-242K
100%
49K
-
-49.50K
-
-49.50K
0%
-11K
77.78%
-11K
0%
dividends paid
other financing activites
13.32M
-
-74K
100.56%
-1.30M
1,655.41%
-1.30M
0%
-1.51M
16.24%
-1.63M
8.01%
1.68M
202.91%
1.63M
2.92%
3.20M
96.62%
-453K
114.14%
4.78M
1,154.08%
4.78M
0%
6.08M
27.30%
6.08M
0%
net cash used provided by financing activities
13.20M
-
26.71M
102.39%
-1.33M
104.97%
-1.33M
0%
-1.63M
22.96%
-2.90M
77.74%
1.68M
157.90%
1.68M
0%
3.20M
90.88%
6.68M
108.46%
4.73M
29.25%
4.73M
0%
6.07M
28.40%
6.07M
0%
effect of forex changes on cash
-48K
-
-48K
0%
-71K
47.92%
-71K
0%
-143K
101.41%
-143K
0%
46.50K
132.52%
46.50K
0%
28.50K
38.71%
28.50K
0%
31K
8.77%
31K
0%
2K
93.55%
2K
0%
net change in cash
8.16M
-
16.32M
100.01%
-4.99M
130.55%
-4.99M
0%
-10.07M
101.97%
-30.12M
199.05%
-6.77M
77.53%
-6.77M
0%
-4.79M
29.16%
-23.13M
382.27%
557K
102.41%
557K
0%
2.40M
331.42%
4.84M
101.41%
cash at beginning of period
37.94M
-
54.26M
43.01%
54.26M
-
24.15M
55.50%
24.15M
-
2.10M
-
cash at end of period
8.16M
-
54.26M
565.03%
49.28M
9.19%
-4.99M
110.12%
-10.07M
101.97%
24.15M
339.76%
17.38M
28.03%
-6.77M
138.95%
-4.79M
29.16%
1.02M
121.29%
557K
45.45%
557K
0%
2.40M
331.42%
6.94M
188.81%
operating cash flow
-5.11M
-
-10.53M
106.15%
-3.46M
67.14%
-3.46M
0%
-8.34M
141.07%
-17.05M
104.35%
-8.53M
49.95%
-8.53M
0%
-8.10M
5.03%
-16.48M
103.34%
-4.23M
74.35%
-4.23M
0%
-3.67M
13.13%
-3.67M
0%
capital expenditure
-5K
-
-10K
100%
-11K
10%
-11K
0%
-74.50K
577.27%
-149K
100%
-51.50K
65.44%
-51.50K
0%
-5K
-
-5K
0%
-500
90%
-500
0%
free cash flow
-5.11M
-
-10.54M
106.14%
-3.47M
67.06%
-3.47M
0%
-8.42M
142.45%
-17.20M
104.31%
-8.58M
50.09%
-8.58M
0%
-8.10M
5.60%
-16.48M
103.34%
-4.23M
74.32%
-4.23M
0%
-3.67M
13.22%
-3.67M
0%

All numbers in EUR (except ratios and percentages)